======= SRGAP1 =======
== Gene Information ==
* **Official Symbol**: SRGAP1
* **Official Name**: SLIT-ROBO Rho GTPase activating protein 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57522|57522]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q7Z6B7|Q7Z6B7]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SRGAP1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SRGAP1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/606523|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is a GTPase activator, working with the GTPase CDC42 to negatively regulate neuronal migration. The encoded protein interacts with the transmembrane receptor ROBO1 to inactivate CDC42. [provided by RefSeq, Sep 2016].
* **UniProt Summary**: GTPase-activating protein for RhoA and Cdc42 small GTPases. Together with CDC42 seems to be involved in the pathway mediating the repulsive signaling of Robo and Slit proteins in neuronal migration. SLIT2, probably through interaction with ROBO1, increases the interaction of SRGAP1 with ROBO1 and inactivates CDC42. {ECO:0000269|PubMed:11672528}.
|SH3 1|
|FCH|
|SH3 2|
|RhoGAP|
|Rac GTPase binding|
|negative regulation of cell migration|
|negative regulation of cell motility|
|GTPase activator activity|
|negative regulation of cellular component movement|
|negative regulation of locomotion|
|regulation of small GTPase mediated signal transduction|
|positive regulation of GTPase activity|
|regulation of GTPase activity|
|positive regulation of hydrolase activity|
|regulation of cell migration|
|regulation of cell motility|
|regulation of locomotion|
|regulation of cellular component movement|
|regulation of hydrolase activity|
|positive regulation of catalytic activity|
|positive regulation of molecular function|
|regulation of intracellular signal transduction|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp151|SGC0946 7μM R03 exp151]]|1.74|
|[[:results:exp465|Cannabidiol 13μM R08 exp465]]|1.82|
|[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|1.89|
^Gene^Correlation^
|[[:human genes:p:prim1|PRIM1]]|0.429|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7175
* **Expression level (log2 read counts)**: 4.7
{{:chemogenomics:nalm6 dist.png?nolink |}}